Claire Dennis is an associate in the Life Sciences and Healthcare Regulatory practice at Arnold & Porter. She represents the FDA-regulated industry across a wide range of topics. Prior to joining Arnold & Porter, Claire was an Associate Chief Counsel at the U.S. Food & Drug Administration for nearly six years where she focused on medical devices, information disclosure, and combination products.
Perspectives
December 4, 2024
LDT Final Rule Litigation — Status of Pending Court Challenges and What May Happen Next
Advisory
Recognition
Commissioner's Special Citation Award
Commissioner's Special Citation Award (2023)
FDA Group Recognition Award
FDA Group Recognition Award (several) (2022-2023)
FDA Outstanding Service Award
FDA Outstanding Service Award (2022)
More
Credentials
Education
- J.D., University of Wisconsin Law School, 2018, with Honors
- M.P.H., University of Wisconsin - Madison, School of Medicine and Public Health, 2018
- B.A., Political Science (Concentration in Bioethics), Yale University, 2013
Admissions
- District of Columbia
- Washington
- Wisconsin
Government & Military Service
- Associate Chief Counsel, U.S. FDA, September 2018-March 2024 (Summer Associate 2017)